Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-091123
Filing Date
2026-08-05
Accepted
2026-08-05 16:17:23
Documents
58
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20260630x10q.htm   iXBRL 10-Q 1567354
2 EX-31.1 ptgx-20260630xex31d1.htm EX-31.1 10112
3 EX-31.2 ptgx-20260630xex31d2.htm EX-31.2 9985
4 EX-32.1 ptgx-20260630xex32d1.htm EX-32.1 10082
5 GRAPHIC ptgx-20260630x10q007.jpg GRAPHIC 65376
6 GRAPHIC ptgx-20260630x10q008.jpg GRAPHIC 61316
  Complete submission text file 0001104659-26-091123.txt   6680490

Data Files

Seq Description Document Type Size
7 EX-101.SCH ptgx-20260630.xsd EX-101.SCH 43300
8 EX-101.CAL ptgx-20260630_cal.xml EX-101.CAL 55084
9 EX-101.DEF ptgx-20260630_def.xml EX-101.DEF 135137
10 EX-101.LAB ptgx-20260630_lab.xml EX-101.LAB 299890
11 EX-101.PRE ptgx-20260630_pre.xml EX-101.PRE 224755
62 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20260630x10q_htm.xml XML 1160192
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 261243821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)